Literature DB >> 680462

Correlation of differences in antigenicity of four 3-methyl-cholanthrene-induced tumors in syngeneic mice with the susceptibility of tumors to an immunopotentiator, PS-K.

S Abe, M Yamazaki, D Mizuno.   

Abstract

Eleven syngeneic tumors were induced by 3-methylcholanthrene in DDD mice. Their antigenicity in vivo was examined by measuring growth inhibition of transplanted tumors in mice immunized by implanting tumors into their tail and then cutting off the tail. Four tumors with different antigenicity were selected from them for study. The growth-suppressive effect of an immunotherapeutic agent, PS-K, on the four tumors was examined. The growth of highly antigenic tumors in mice was inhibited by PS-K, but that of weakly antigenic tumors was not, and a close correlation was found between the antigenicity of tumors and the antitumor activity of PS-K against them. No similar correlation was found between their antigenicity and their sensitivity to a mitotic poison, 6-mercaptopurine. These results suggest that the antitumor effect of an immunopotentiator depends greatly on the antigenicity of tumors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 680462

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  3 in total

1.  Depression of protective mechanism during the early phase of a viral infection in tumor-bearing mice and prevention by PSK.

Authors:  S Tsuru; K Nomoto; M Taniguchi; H Fujisawa; Y Zinnaka
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites.

Authors:  M Hosokawa; T Mizukoshi; K Morikawa; Z Y Xu; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Depression of macrophage functions and T-cell-mediated immunity to listeria infection in tumor-bearing mice and its prevention by PSK.

Authors:  S Tsuru; K Nomoto; M Taniguchi; H Kitani; M Watanabe; Y Zinnaka
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.